HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Kawamoto Selected Research

Prostaglandin E Receptors (Prostaglandin E Receptor)

7/2003Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis.
4/2002Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toru Kawamoto Research Topics

Disease

24Neoplasms (Cancer)
01/2016 - 01/2002
15Carcinoma (Carcinomatosis)
05/2015 - 03/2002
7Neoplasm Metastasis (Metastasis)
01/2006 - 01/2002
5Gallbladder Neoplasms (Gallbladder Cancer)
01/2016 - 09/2003
3Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2020 - 06/2007
3Infections
11/2017 - 11/2003
3Carcinogenesis
01/2016 - 11/2003
3Cholangiocarcinoma
06/2013 - 12/2008
2Abdominal Pain (Pain, Abdominal)
06/2016 - 07/2004
2Ischemia
10/2013 - 01/2006
2Adenocarcinoma
08/2010 - 05/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2010 - 01/2010
2Colonic Neoplasms (Colon Cancer)
01/2006 - 09/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016
1Pancreaticobiliary Maljunction
01/2016
1Bile Duct Diseases (Bile Duct Disease)
06/2013
1Hypoxia (Hypoxemia)
08/2010
1Inflammation (Inflammations)
08/2008
1Pancreatic Diseases (Pancreatic Disease)
08/2008
1Lung Neoplasms (Lung Cancer)
11/2007
1Adenoma (Adenomas)
03/2005
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2005
1Colic (Abdominal Cramps)
09/2004
1Diarrhea
07/2004
1Proctocolitis (Hemorrhagic Proctocolitis)
07/2004
1Hyperemia
07/2004
1Chronic Idiopathic Jaundice (Dubin Johnson Syndrome)
12/2003
1Genomic Instability
11/2003

Drug/Important Bio-Agent (IBA)

9Biological ProductsIBA
04/2014 - 03/2002
7Messenger RNA (mRNA)IBA
01/2010 - 03/2002
5Biomarkers (Surrogate Marker)IBA
05/2015 - 01/2004
5Proteins (Proteins, Gene)FDA Link
04/2014 - 04/2002
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2008 - 03/2002
3ErbB Receptors (EGF Receptor)IBA
11/2007 - 08/2005
3Monoclonal AntibodiesIBA
11/2004 - 01/2004
3Cadherins (E-Cadherin)IBA
01/2004 - 01/2002
2TOR Serine-Threonine KinasesIBA
05/2015 - 04/2007
2LigandsIBA
11/2014 - 01/2010
2wisteria lectinIBA
06/2013 - 07/2010
2Polysaccharides (Glycans)IBA
05/2008 - 03/2005
2Therapeutic UsesIBA
06/2007 - 04/2007
2Prostaglandins EIBA
07/2003 - 04/2002
2Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
07/2003 - 04/2002
1AcidsIBA
11/2017
1Indicators and Reagents (Reagents)IBA
11/2017
1Pyrantel Pamoate (Pyrantel Embonate)IBA
06/2016
1phytobacteriomycin (PBM)IBA
01/2016
1Keratins (Keratin)IBA
01/2016
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
05/2015
1pertuzumabIBA
04/2015
1Small Interfering RNA (siRNA)IBA
04/2014
1AcetylglucosamineIBA
04/2014
1EnzymesIBA
04/2014
1AsparagineIBA
04/2014
1OligosaccharidesIBA
04/2014
1alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
04/2014
1C-Reactive ProteinIBA
04/2014
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
06/2013
1Contrast MediaIBA
08/2010
1Oxygen (Dioxygen)IBA
08/2010
1SonazoidIBA
08/2010
1Mucin-1 (CA 15-3 Antigen)IBA
07/2010
1cyclopamineIBA
01/2010
1Zinc Finger Protein Gli2IBA
01/2010
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2010
1Immunotoxins (Immunotoxin)IBA
12/2008
1Cell Surface ReceptorsIBA
12/2008
1Cytotoxins (Cytolysins)IBA
12/2008
1ExotoxinsIBA
12/2008
1Interleukin-4 (Interleukin 4)IBA
12/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2007
1apricoxibIBA
06/2007
1Sirolimus (Rapamycin)FDA Link
04/2007
1MacrolidesIBA
04/2007
1E-SelectinIBA
01/2006
1AntithrombinsIBA
01/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006
1Gefitinib (Iressa)FDA Link
08/2005
1Tyrosine Kinase InhibitorsIBA
08/2005
1UDP-GlcNAc GalNAc-peptide beta1,3-N-acetylglucosaminyltransferaseIBA
03/2005
1GalactosamineIBA
03/2004
1IsoenzymesIBA
03/2004
1MucinsIBA
03/2004
1Uridine Diphosphate (UDP)IBA
03/2004
1Polypeptide N-acetylgalactosaminyltransferaseIBA
03/2004
1Multidrug Resistance-Associated Protein 2IBA
12/2003
1Carcinoembryonic AntigenIBA
12/2003
1ParaffinIBA
11/2003
1Mitochondrial DNA (mtDNA)IBA
11/2003
1Formaldehyde (Formol)FDA Link
11/2003

Therapy/Procedure

8Therapeutics
01/2020 - 03/2003
3Drug Therapy (Chemotherapy)
01/2020 - 01/2003
3Lymph Node Excision (Lymph Node Dissection)
09/2004 - 12/2000
2Radiotherapy
01/2020 - 01/2003
2Adjuvant Chemotherapy
09/2004 - 03/2003
1Cholecystectomy
01/2016
1Intramuscular Injections
10/2013
1Intravenous Administration
08/2010
1Microbubbles
08/2010
1Ligation
07/2004